Clinical Trials Directory

Trials / Completed

CompletedNCT05140642

Safety and Efficacy Study of AI LVEF

Blinded Randomized Controlled Trial of Artificial Intelligence Guided Assessment of Cardiac Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,495 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
All
Age
18 Years – 110 Years
Healthy volunteers
Not accepted

Summary

To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in preliminary readings of echocardiograms.

Conditions

Interventions

TypeNameDescription
OTHERAutomated annotation of the left ventricle through deep learningA semantic segmentation deep learning model will identify the left ventricle and label the left ventricle. The AI model will produce an assessment of LVEF using video based features.
OTHERSonographer Measurement of LVEFStandard practice sonographer measurement of left ventricle and assessment of LVEF

Timeline

Start date
2022-04-01
Primary completion
2022-06-29
Completion
2022-06-29
First posted
2021-12-01
Last updated
2022-07-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05140642. Inclusion in this directory is not an endorsement.